Company Filing History:
Years Active: 2006
Title: Bert Steffen Rosén: Innovator in Blood Coagulation Screening
Introduction
Bert Steffen Rosén is a notable inventor based in Kållered, Sweden. He has made significant contributions to the field of blood coagulation disorders through his innovative patent. His work focuses on improving the methods for screening and determining the functional activity of components involved in the Protein C anticoagulant pathway.
Latest Patents
Bert Steffen Rosén holds a patent for "Kits for screening for blood coagulation disorders." This patent describes in vitro methods for qualitative screening and quantitative determination of the functional activity of components of the Protein C anticoagulant pathway. The methods involve measuring the conversion rate of a substrate by an enzyme related to Protein C anticoagulant activity in a human blood sample. The process includes partial activation of coagulation and the addition of calcium ions, followed by a comparison with a normal human blood sample. Additionally, the methods enhance activity, sensitivity, and resolution by incorporating additional metal ions. The patent also provides kits and reagents for use in these methods.
Career Highlights
Bert Steffen Rosén is associated with Instrumentation Laboratory S.p.a., where he continues to contribute to advancements in medical technology. His expertise in blood coagulation has positioned him as a key figure in the development of diagnostic tools that improve patient care.
Collaborations
Bert collaborates with Christina Maria Yvonne Hall, who is also involved in the field of blood coagulation research. Their partnership exemplifies the importance of teamwork in driving innovation and enhancing the effectiveness of medical diagnostics.
Conclusion
Bert Steffen Rosén's contributions to blood coagulation screening represent a significant advancement in medical diagnostics. His innovative methods and collaborative efforts continue to impact the field positively.